Rossana Tonlorenzi

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Correction: Mesoangioblasts at 20: from the embryonic aorta to the patient bed.

Correction: Mesoangioblasts at 20: from the embryonic aorta to the patient bed.

Journal: Frontiers in genetics
Published: May 18, 2026

Author Correction: Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy.

Author Correction: Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy.

Journal: EMBO molecular medicine
Published: September 06, 2024

Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy.

Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy.

Journal: EMBO molecular medicine
Published: February 27, 2023

Mesoangioblasts at 20: From the embryonic aorta to the patient bed.

Mesoangioblasts at 20: From the embryonic aorta to the patient bed.

Journal: Frontiers in genetics
Published: September 28, 2022

Mesoangioblasts at 20: From the embryonic aorta to the patient bed.

Mesoangioblasts at 20: From the embryonic aorta to the patient bed.

Journal: Frontiers in genetics
Published: September 28, 2022

Alteration of the late endocytic pathway in Charcot-Marie-Tooth type 2B disease.

Alteration of the late endocytic pathway in Charcot-Marie-Tooth type 2B disease.

Journal: Cellular and molecular life sciences : CMLS
Published: September 17, 2019

Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.

Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.

Journal: EMBO molecular medicine
Published: December 16, 2017

Isolation and Characterization of Vessel-Associated Stem/Progenitor Cells from Skeletal Muscle.

Isolation and Characterization of Vessel-Associated Stem/Progenitor Cells from Skeletal Muscle.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 02, 2017

Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy.

Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy.

Journal: EMBO molecular medicine
Published: December 03, 2016

Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy.

Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy.

Journal: EMBO molecular medicine
Published: November 07, 2015

Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A.

Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A.

Journal: Skeletal muscle
Published: February 11, 2015

PW1/Peg3 expression regulates key properties that determine mesoangioblast stem cell competence.

PW1/Peg3 expression regulates key properties that determine mesoangioblast stem cell competence.

Journal: Nature communications
Published: May 07, 2014
Showing 1-12 of 19

Last Updated: 09/26/2026